Edward Alan Neugeboren
Independent DirectorMr. Edward Alan Neugeboren is Independent Director of Grace Therapeutics, Inc. from October 10, 2023. Mr. Edward Alan Neugeboren serves as Independent Director at Matinas BioPharma Holdings, Inc. from March 11, 2025. He is Independent Director of Acasti Pharma Inc. from October 10, 2023. He serves as Member of Board Advisors at Healthcare Capital Corp. Mr. Neugeboren is a Member of Advisory Board at Healthcare Capital Corp Delaware. He is the Chief Strategy Officer of Rising Pharma Holdings, Inc and Grace Therapeutics, Inc. He has been Chief Strategy Officer of Casper Pharma LLC since May 23, 2016. Mr. Neugeboren serves as an Executive Director of Ledgemont Energy Partners LP. Mr. Neugeboren is a Founder and Managing Partner of QuadView Healthcare Advisors. He served as Managing Director at Ledgemont Capital Group, LLC (formerly Indigo Merchant Capital Group). Earlier, Mr. Neugeboren was a Managing Partner at Third Ridge Capital Management LLC from 2001 to 2003. He served as Chief Administrative Officer at Sorceron Inc. from 2000 to 2001. He has over 23 years of healthcare experience in investment banking, business development, portfolio management, corporate management and institutional equity research. Mr. Neugeboren has served as the Chief Strategy Officer of Cronus Pharma, LLC, a fully integrated R&D, manufacturing and sales & marketing animal health pharmaceutical company. Mr. Neugeboren was previously Co-Founder and Managing Partner at ArcLight Advisors. He is employee at IndiGo Ventures LLC. Mr. Neugeboren served as Chief Administrative Officer and Director of Equity Research Operations of Lehman Brothers from 1998 to 2000. Before this, he served as a Senior Member of the management team responsible for operations for a 200 person department. Earlier, he was Deputy Director of Equity Research at UBS Investment Bank, Research Division (formerly Warburg Dillon Read) from 1996 to 1998 and Director of Equity Research Operations from 1995 to1996. He served as a senior member of the management team responsible for operations for a 150 person department. Mr. Neugeboren began his career in 1992 as an Equity Research Analyst covering the Specialty Pharmaceuticals industry, including Generic Drugs and Drug Delivery at Dillon, Read & Co., Kidder, Peabody & Co. and Furman, Selz Inc. He served as a member of top ranked Greenwich Associates Mid-Cap Pharmaceuticals Team. Mr. Neugeboren served as Director of KineMed Inc. He served as Director of Elite Pharmaceuticals Inc. from January 25, 2005 to June 25, 2007. He graduated with a B.S. in Economics from Union College in 1992.
Positions
- Company NameMatinas BioPharma Holdings, Inc.Stock CodeMTNBPositionIndependent Director
